SIGNIFICANT DISEASE BURDEN EVALUATED BY FACIT-FATIGUE AND EORTC QLQ-C30 IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA FROM A KOREAN PROSPECTIVE PNH REGISTRY

続きを見る

PARAMETERS OF CELL IMMUNITY IN PATIENTS WITH APLASTIC ANEMIA AND THEIR RELATION TO PNH-CLONE

続きを見る

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CLINICAL EXPRESSION AND RESPONSE TO TREATMENT ARE MODIFIED BY A UNIQUE INTERACTION WITH CO-EXISTING GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY

続きを見る

PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONES EMERGED AFTER IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH SEVERE OR NON-SEVERE APLASTIC ANEMIA

続きを見る

THROMBOEMBOLISM OCCURRED REGARDLESS OF HEMOLYSIS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA– A PROSPECTIVE STUDY OF 464 PATIENTS IN A MULTICENTER CHINESE REGISTRY

続きを見る